536 related articles for article (PubMed ID: 17973815)
21. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
22. Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus.
Kárpáti S; Amagai M; Liu WL; Dmochowski M; Hashimoto T; Horváth A
Exp Dermatol; 2000 Jun; 9(3):224-8. PubMed ID: 10839721
[TBL] [Abstract][Full Text] [Related]
23. Anti-desmoglein 1 IgG/IgA pemphigus associated with thymoma.
Reichel A; Benoit S; Giner T; Schmidt E; Goebeler M; Stoevesandt J
J Dtsch Dermatol Ges; 2017 Nov; 15(11):1147-1148. PubMed ID: 29030953
[No Abstract] [Full Text] [Related]
24. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
[TBL] [Abstract][Full Text] [Related]
25. Neutrophilic spongiosis in pemphigus.
Hoss DM; Shea CR; Grant-Kels JM
Arch Dermatol; 1996 Mar; 132(3):315-8. PubMed ID: 8607637
[TBL] [Abstract][Full Text] [Related]
26. IgG/IgA pemphigus reactive with desmoglein 1 with additional undetermined reactivity with epidermal basement membrane zone.
Kanwar AJ; Vinay K; Saikia UN; Koga H; Teye K; Tsuruta D; Hashimoto T
Indian J Dermatol Venereol Leprol; 2014; 80(1):46-50. PubMed ID: 24448124
[TBL] [Abstract][Full Text] [Related]
27. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
28. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
Eming R; Rech J; Barth S; Kalden JR; Schuler G; Harrer T; Hertl M
Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825
[TBL] [Abstract][Full Text] [Related]
29. Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.
Daneshpazhooh M; Kamyab K; Kalantari MS; Balighi K; Naraghi ZS; Shamohammadi S; Mortazavizadeh SM; Ramezani A; Chams-Davatchi C
Clin Exp Dermatol; 2014 Jan; 39(1):41-7. PubMed ID: 23782219
[TBL] [Abstract][Full Text] [Related]
30. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
Abasq C; Mouquet H; Gilbert D; Tron F; Grassi V; Musette P; Joly P
Arch Dermatol; 2009 May; 145(5):529-35. PubMed ID: 19451496
[TBL] [Abstract][Full Text] [Related]
31. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
Kwon EJ; Yamagami J; Nishikawa T; Amagai M
J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
[TBL] [Abstract][Full Text] [Related]
32. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
[No Abstract] [Full Text] [Related]
33. Pemphigus vulgaris presenting in a radiation portal.
Robbins AC; Lazarova Z; Janson MM; Fairley JA
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S82-5. PubMed ID: 17434046
[TBL] [Abstract][Full Text] [Related]
34. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
35. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
[TBL] [Abstract][Full Text] [Related]
36. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
[TBL] [Abstract][Full Text] [Related]
38. Pemphigus of the eyelids.
Seishima M; Oyama Z; Shimizu H; Naganawa Y; Yoshimura T; Yamazaki F
Eur J Dermatol; 2001; 11(2):141-3. PubMed ID: 11275814
[TBL] [Abstract][Full Text] [Related]
39. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
Laffitte E; Panizzon RG; Borradori L
Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
[TBL] [Abstract][Full Text] [Related]
40. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.
Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T
J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
